Work

Efficacy and safety of heterologous booster vaccination with Ad26.COV2.S after BNT162b2 mRNA COVID‐19 vaccine in haemato‐oncological patients with no antibody response

Year: 2021

Type: article

Study design: Clinical Trial

Source: British Journal of Haematology

DOI: 10.1111/bjh.17982

Authors: Patrick Reimann, Hanno Ulmer, Beatrix Mutschlechner, Magdalena Benda, Luciano Severgnini, Andreas Volgger, Theresia Lang, Michele Atzl, Minh Huynh, Klaus Gasser, Claudia Grabher, Sylvia Mink, Peter Fraunberger, Ulf Petrausch, Bernd Hartmann, Thomas Winder

Institutions: Landeskrankenhaus Feldkirch, Private University in the Principality of Liechtenstein, Innsbruck Medical University, Universität Innsbruck, University of Zurich

Language: English

Topic: SARS-CoV-2 and COVID-19 Research

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4200529027

FWCI: 3.062

Cites: 21

Cited by: 41

Related to: 10